PFE stock falls as Pfizer downgraded at UBS on COVID worries (NYSE:PFE)

Pfizer world headquarters in New York City, USA.


Pfizer (NYSE:PFE) shares dropped ~1% pre-market Thursday as UBS became the latest investment firm to downgrade the COVID-19 vaccine maker citing the declining pandemic impact.

The rating change follows a ~14% drop in Pfizer (PFE) shares over the pastto its COVID franchise.

Source link

5 Trading strategies to make money

Looking to boost your trading profits?

Get you copy of our FREE Ebook Now !!!